Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Program Official Sort descending
Kassie, Fekadu

University Of Minnesota
United States

Targeting tumor cell mitochondria for the prevention and treatment of lung cancer 5R01CA285608-02 John Clifford, Ph.D.
Li, Chi

University Of Louisville
United States

A lung cancer vaccine based on exosomes of induced pluripotent stem cells 1R21CA280453-01 John Clifford, Ph.D.
Mittal, Vivek

Weill Medical Coll Of Cornell Univ
United States

CAP-IT Center for LNP RNA Immunoprevention 5U54CA272688-04 John Clifford, Ph.D.
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 5R01CA280746-03 John Clifford, Ph.D.
Jang, Mi-Hyeon

Rutgers Biomedical And Health Sciences
United States

Identification of novel biomarkers and therapeutic strategies in chemobrain. 5R01CA293210-02 John Clifford, Ph.D.
Guo, Xingyi

Vanderbilt University Medical Center
United States

Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug Repurposing 1R01CA297582-01A1 Gary Della'Zanna, D.O., M.Sc.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 5R21CA280230-02 Eileen Dimond, R.N., M.S.
Xu, Chunhui

Emory University
United States

High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes 1R21CA285254-01A1 Eileen Dimond, R.N., M.S.
Upshaw, Jenica

Beth Israel Deaconess Medical Center
United States

A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S.
Hundley, William Gregory

Wake Forest University Health Sciences
United States

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-05 Eileen Dimond, R.N., M.S.